Our 2025 Impact Report is Live — See what we are building together >

Search

LabCentral signs Science Exchange: Outsourced services "increasingly important'

Just months after expanding, LabCentral growing again

Vedanta Biosciences Expands Network of Clinical Collaborations Supporting Development of Microbiome Therapeutics for Cancer Immunotherapy

Six grand ideas to fight the end of antibiotics

Kymera Emerges Out of Stealth Mode With $30M and a Top Team of Drug Hunters

How a Silkworm's Threads Could Repair Spinal Cords

Kymera launches with $30 million to tackle targeted protein degradation

Gallery 1832 at LabCentral’s Grand Opening

Enhanced understanding of the microbiome is helping medicine

Biotech firms race to recruit good bugs in war on cancer